SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced preliminary revenue for the fourth quarter and full year ended December 31, 2016. Total revenue for the fourth quarter of 2016 is expected to be in the range of approximately $24.7 million to $25.2 million based on preliminary, unaudited financial data. At the midpoint of the […]

New fluorescence option enables specific applications in cell line development Bournemouth, UK – Solentim, the developer of instrumentation for cell line development, announced today that it has launched a major enhancement for its world leading verification of clonality platform, the Cell Metric®. This enhancement, which enables two channel fluorescence on the Cell Metric and Cell Metric […]